Your browser doesn't support javascript.
loading
Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Dilley, James; Burnell, Matthew; Gentry-Maharaj, Aleksandra; Ryan, Andy; Neophytou, Christina; Apostolidou, Sophia; Karpinskyj, Chloe; Kalsi, Jatinderpal; Mould, Tim; Woolas, Robert; Singh, Naveena; Widschwendter, Martin; Fallowfield, Lesley; Campbell, Stuart; Skates, Steven J; McGuire, Alistair; Parmar, Mahesh; Jacobs, Ian; Menon, Usha.
Afiliação
  • Dilley J; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, UK.
  • Burnell M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, UK.
  • Gentry-Maharaj A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, UK.
  • Ryan A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, UK.
  • Neophytou C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, UK.
  • Apostolidou S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, UK.
  • Karpinskyj C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, UK.
  • Kalsi J; Institute for Women's Health, University College London, UK.
  • Mould T; University College London Hospital, UK.
  • Woolas R; Queen Alexandra Hospital, Portsmouth, UK.
  • Singh N; Barts Health NHS Trust, UK.
  • Widschwendter M; Institute for Women's Health, University College London, UK.
  • Fallowfield L; Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, UK.
  • Campbell S; Create Health London, UK.
  • Skates SJ; Massachusetts General Hospital and Harvard Medical School, USA.
  • McGuire A; London School of Economics, UK.
  • Parmar M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, UK.
  • Jacobs I; University of New South Wales, Australia.
  • Menon U; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, UK. Electronic address: u.menon@ucl.ac.uk.
Gynecol Oncol ; 158(2): 316-322, 2020 08.
Article em En | MEDLINE | ID: mdl-32561125

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Carcinoma Epitelial do Ovário Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Gynecol Oncol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Carcinoma Epitelial do Ovário Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Gynecol Oncol Ano de publicação: 2020 Tipo de documento: Article